Influence of SARS-CoV-2 reinfection on bone health in the population over 55 years old in Beijing, China: a cross-sectional study
Frontiers in Public Health · 19.02.2026 · 14
DOI: 10.3389/fpubh.2026.1758835 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Public Health, online erschienen am 19.02.2026. Verfasst von Qian Qiu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Center for Diseases Prevention and Control, Beijing, China. Hauptthemen laut MEDLINE: COVID-19, Bone Density, Osteoporosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Despite the global prevalence of SARS-CoV-2 reinfection, relatively little is known regarding its association with osteoporosis in older adults. This study investigated the potential impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on bone health or osteoporosis risk in adults aged 55 years and older in Beijing, China, while also exploring additional factors that may influence this association.
Methods
This cross-sectional study was conducted at Beijing Ditan Hospital, Beijing, China, between August and December 2024. Patients aged ≥ 55 years with SARS-CoV-2 infections were included. Data on demographic characteristics, lifestyle habits, diet, serum contents of 25-hydroxyvitamin D (25-OH-VD), and other potential risk factors for osteoporosis were collected through structured questionnaires. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry (DXA). To identify the variables associated with osteoporosis, logistic regression analysis was employed.
Results
Three hundred and eighty-eight patients were enrolled, comprising 272 individuals with a single SARS-CoV-2 infection and 116 with two or more infections. The results revealed that individuals who had reinfection revealed a considerably higher prevalence of osteoporosis (48.3% vs. 17.3%, p < 0.0001). This trend was consistent across different skeletal sites: 33.6% vs. 7.4% at the left hip, 37.9% vs. 5.5% at the right hip ( p < 0.0001), and 30.2% vs. 12.9% at the lumbar spine (L1–L4) ( p < 0.0001). SARS-CoV-2 reinfection remained substantially associated with osteoporosis after controlling for con-founding variables, with an OR of 3.08 (95% CI: 1.696–5.593).
Conclusion
In summary, the risk of osteoporosis among individuals with SARS-CoV-2 reinfection should be carefully monitored, and greater emphasis should be placed on early, individualized prevention and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing Center for Diseases Prevention and Control, Beijing, China.
- Capital Medical University, Beijing, China.
- Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
- Cuigezhuang Community Health Service Center, Beijing, China.
- Department of Orthopedic Trauma, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
- Beijing Research Institute of Traumatology and Orthopaedics, Beijing, China.
Zitieren
APA
Qiu, Q., Wu, T., Jiang, Y., Shang, Z., Shi, W., Zhang, X., Han, X., Yang, Z., Jiang, X., & Liu, X. (2026). Influence of SARS-CoV-2 reinfection on bone health in the population over 55 years old in Beijing, China: a cross-sectional study. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1758835
Vancouver
Qiu Q, Wu T, Jiang Y, Shang Z, Shi W, Zhang X, et al. Influence of SARS-CoV-2 reinfection on bone health in the population over 55 years old in Beijing, China: a cross-sectional study. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1758835
BibTeX
@article{Qiu2026,
author = {Qiu, Qian and Wu, Tong and Jiang, Yuyong and Shang, Zimeng and Shi, Wanxin and Zhang, Xiaohui and Han, Xu and Yang, Zhiyun and Jiang, Xieyuan and Liu, Xiuying},
title = {Influence of SARS-CoV-2 reinfection on bone health in the population over 55 years old in Beijing, China: a cross-sectional study},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1758835}
}
EUVIMED